(6-036) Evaluation of Rituximab Therapy for Immune-based Hematologic Disorders: Acquired Hemophilia a (AHA) and Acquired Thrombotic Thrombocytopenic Purpura (TTP)
Tuesday, December 6, 2022
10:45 AM – 11:45 AM
Location: Bayside A, Level 1
Category: Evaluative Study Topic: Oncology/Hematology
